SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001408408-21-000011
Filing Date
2021-03-15
Accepted
2021-03-15 16:45:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A ecl_mrkr13da03152021.htm SC 13D/A 51671
2 JOINT FILING AGREEMENT ecl_mrkr13daex1.htm EX-1 6743
  Complete submission text file 0001408408-21-000011.txt   60204
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Subject) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-58217 | Film No.: 21742070
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 MARKET STREET, #773 CAMANA BAY GRAND CAYMAN E9 KY1-9006
Business Address 10 MARKET STREET, #773 CAMANA BAY GRAND CAYMAN E9 KY1-9006 345-640-3300
Eastern Capital LTD (Filed by) CIK: 0001408408 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: SC 13D/A